NanoSynex
Business Services · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
7 Pinhas Sapir, Ness Ziona, 740361, Isra...Website
www.nanosynex.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About NanoSynex
NanoSynex is a MedTech company focused on improving testing quality and reducing healthcare costs through faster diagnostic processes. Their mission is to combat antibiotic resistance by enabling rapid and personalized diagnosis, allowing for targeted antibiotic prescriptions. The company aims to address the growing threat of superbugs, which claim hundreds of thousands of lives annually due to antibiotic misuse. Intended clients include healthcare providers and institutions seeking innovative solutions for bacterial diagnosis and treatment.Explore more
NanoSynex Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is NanoSynex your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if NanoSynex had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at NanoSynex
Earning: See what the market has to say on NanoSynex recently announced quarterly report
NanoSynex, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once NanoSynex has new funding data
Product Launch: Get notified when NanoSynex launches new products
Check if NanoSynex has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Check out if NanoSynex is spiking on competitors!
Recommended Actions
Find VP level buyers at NanoSynex
Find 2 more new buyers
Company Profile Activity
Activity Insights
NanoSynex is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
NanoSynex is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about NanoSynex.
NanoSynex Tech Stack
A closer look at the technologies used by NanoSynex
See more technologies
NanoSynex News & Media
Qualigen Therapeutics Provides Update on Developments at NanoSynex; Significant Progress Reported on Infectious Disease Diagnostic Platform
CARLSBAD, Calif., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (“Qualigen” or “the Company,” Nasdaq: QLGN), a diversified life sciences company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation, while also commercializing diagnostics, today shares an update on its majority-owned subsidiary, NanoSynex Ltd. (“NanoSynex”), the progress made during 2022, and objectives for 2023 concerning the commercialization plans for its iQualigen stock rises on acquiring majority stake in Israeli diagnostics company NanoSynex
Qualigen Therapeutics (QLGN) stock rose June 2 after the company said it completed the acquisition of a majority stake in Israeli diagnostics company NanoSynex.Qualigen said...Qualigen Therapeutics Acquires Majority Stake in Infectious Disease Diagnostics Technology Company NanoSynex
Transaction expected to significantly advance commercial readiness of NanoSynex’s innovative diagnostics technology platform focused on the $30+ Billion global infectious disease testing market
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding NanoSynex
Sign Up For FreeTo access detailed company insights
NanoSynex is a MedTech company focused on improving testing quality and reducing healthcare costs through faster diagnostic processes. Their mission is to combat antibiotic resistance by enabling rapid and personalized diagnosis, allowing for targeted antibiotic prescriptions. The company aims to address the growing threat of superbugs, which claim... Read More
